Skip to main content
. 2011 Apr 13;93(6):1248–1254. doi: 10.3945/ajcn.110.009043

TABLE 4.

Amino acids, urea, and carbon dioxide kinetics in partial– and null–ornithine transcarbamylase–deficient (partial- and null-OTCD) subjects who received treatment with sodium phenylbutyrate (10 g · m−2 · d−1) or phenylbutyrate plus branched-chain amino acid (BCAA) supplementation1

Partial-OTCD subjects (n = 7)2
Null-OTCD subjects (n = 3)2
P values
Item Phenylbutyrate BCAA Phenylbutyrate BCAA Pooled SEM3 TRT Gen TRT × Gen
Flux (μmol · kg−1 · h−1)
 Urea 121 117 99 82 21.7 <0.575 <0.145 <0.736
 Phenylalanine 43 44 41 41 2.8 <0.550 <0.805 <0.794
 Tyrosine 45 46 49 41 3.4 <0.466 <0.815 <0.344
 Leucine 127 162 106 147 16.5 <0.096 <0.407 <0.902
 Glutamine 263 298 302 298 26.7 <0.286 <0.242 <0.947
 CO2 (×100) 134 138 131 132 15.8 <0.900 <0.829 <0.963
Rate of conversion (μmol · kg−1 · h−1)
 Gln→urea 19 26 27 31 6.5 <0.376 <0.290 <0.796
 Phe→Tyr 8 8 8 7 1.3 <0.753 <0.852 <0.510
 Leu→CO2 44 56 28 39 4.6 <0.093 <0.026 <0.923
1

TRT, treatment (phenylbutyrate compared with phenylbutyrate plus BCAA treatments); Gen, genotype (partial-OTCD compared with null-OTCD subjects); TRT × Gen, interaction of main effects; Gln→urea, rate of transfer of the amido group of glutamine to urea; Phe→Tyr, rate of conversion of phenylalanine to tyrosine; Leu→CO2, rate of conversion of leucine to carbon dioxide. Data were analyzed by using mixed models (fixed effects for TRT, Gen, and TRT × Gen; random effects for subject).

2

Values are means.

3

On the basis of n = 7.